# Neuphoria Therapeutics Inc.: Form 8-K, filed Jul 24, 2026

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: 8-K
- Filed: 2026-07-24
- Accepted by EDGAR: Jul 23, 2026, 22:37 ET
- Period: 2026-07-20
- Accession: 0001213900-26-081052
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000121390026081052/ea0298914-8k_neuphoria.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000121390026081052/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.01: Change in control
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000121390026081052/ea0298914-8k_neuphoria.htm

Filed Jul 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-081052. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.